Low-dose lithium dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
The tap water studies people quote are not tests on people.
Evidence grade for Low-dose lithium: Moderate. The rule: at least one finished study in people, and at least 100 people who took it. The sum on this page: 3 completed trials, 106 people given it. A grade counts how much has been done to people, not whether it works.
- People given it
- 106
- Human studies
- 3
- Found nothing
- 0
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
3 completed trials, 106 people given it
5 effects reported, 4 unwanted, 1 wanted, by people using it, not a trial
Goal pages: Brain, memory and mood, Ageing and longevity
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
Low-dose lithium usually means lithium orotate, a supplement with a few milligrams of lithium. That is about a hundred times less than prescription lithium. People take it for mood and brain health.
What people take it for
- Calmer mood and less anxiety.
- Protecting the brain from Alzheimer's disease.
- Living longer, based on tap water studies.
What studies in people showed
The tap water studies compare places, not people. One covered 1,206,174 people in 18 Japanese towns. More lithium in the water went with fewer deaths. Another pooled 15 studies and linked more lithium with fewer suicides. The real tests used prescription lithium at much higher doses. In 61 people with mild memory problems, the lithium group held steady for two years while the dummy group declined. One small study used a low dose of 300 micrograms a day in Alzheimer's disease. Scores held steady, and nobody has repeated it. Now the mice. Cutting lithium from their food sped up memory loss.
What people report
Reports, not study results
The good
- Some people describe a mild drop in anxiety at a few milligrams a day.
The bad
- Others at the same dose describe heavy brain fog, short-term memory problems and sleepiness within an hour.
- Muscle twitching is reported. The usual reply, that the dose is too small to cause it, is reassurance, not proof.
- Many people notice nothing, and that is treated as expected.
- No blood test shows whether a supplement dose is doing anything.
Where these come from: LongeCity brain health and supplement threads, read through search extracts in September 2026, plus the studies on this page. Forum reports are not from a study.
My bottom line
The real evidence is for prescription lithium with blood checks, not the supplement. If memory is your worry, see a doctor and get tested. Do not self-dose on the strength of tap water maps.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Measured in people
Goals Low-dose lithium has been tested for in people, biggest studies first. We count only what the studies on this page say, so the real numbers may be higher.
- Memory and thinking106 people · 3 studies
- Living longerno headcount stated · 1 study
What people using it report
Real people telling you what happened to them. Nobody checked it, and the people who post are not a fair sample, so it cannot prove anything works. It is still the best guide on this page to what people actually do with Low-dose lithium, what they expect, and what goes wrong. The full account, including the negative reports, is below.
33 of the 36 indexed goals have no study of any kind behind Low-dose lithium
No study in people, animals or cells on this page reports a result for these. That does not prove Low-dose lithium does nothing for them. It does mean anything you have heard about Low-dose lithium and one of these did not come from a study cited here.
Show full evidence
What is Low-dose lithium?
The tap water studies people quote are not tests on people. A review pooled 15 studies that compared lithium in local water with local suicide rates. Places with more lithium had fewer suicides, but the authors warn that patterns across places may not apply to people. The studies that actually gave people lithium used prescription lithium carbonate at 150 to 600 mg, adjusted by blood test. That is a different thing from the few milligrams of lithium orotate sold in shops.
Low-dose lithium is a whole product category built on a kind of study that cannot support it. And the real tests in people used a different dose of a different form.
The popular case rests on studies of places. They compare lithium in the tap water of counties or towns with death rates in those same places. A review pooled 15 of them. Places with more lithium in the water had fewer suicides, a link too steady to be chance. But the studies disagreed a lot with each other. The authors' own conclusion opens by naming the problem. These studies compare places, not people, and that can mislead. They suggest the real test would be to add lithium to some water supplies and not others, chosen by chance. Nobody has done that. A separate paper looked at 18 Japanese towns covering 1,206,174 people. Towns with more lithium in their tap water had fewer deaths from any cause. The same paper put tiny worms in a similar low level of lithium, and the worms lived longer.
A pattern across places tells you about places, not people. Nobody in those data sets had their own lithium intake measured. No one person's health was linked to their own lithium intake.
The studies that actually gave people lithium are separate, and more interesting. It is important to be precise about the dose. In 45 people with mild memory problems, a year of lithium carbonate, adjusted to a low blood level of 0.25 to 0.5 mmol/L, lowered a tau protein in spinal fluid. Tau is linked to Alzheimer's disease. It also improved two thinking measures. A follow-up in 61 people over two years found the dummy-pill group declined while the lithium group held steady. Memory and attention were better at 24 months, and an amyloid measure in spinal fluid rose at 36 months. Those are real results. They used prescription lithium carbonate, in the 150 to 600 mg range, checked by blood test. A lithium orotate capsule usually gives a few milligrams of lithium itself, roughly a hundred times less. It produces no level you can measure in the blood.
There is one real low-dose study. People with Alzheimer's disease took 300 micrograms of lithium a day for fifteen months. The treated group did not lose points on a memory and thinking test, while the untreated group did. It is one small study, and nobody has repeated it.
The newest work is in mice and in human brain tissue after death. It is not a study in living people. A 2025 paper in Nature reported that the brain's own lithium is lower in people with mild memory problems. Cutting lithium from the diet of mice raised amyloid and tau and sped up memory decline. Lithium orotate prevented those changes in mice. That is a strong reason to run a human study. It is not a human study.
How does Low-dose lithium work?
Lithium blocks an enzyme called GSK3 beta. That enzyme sits upstream of tau build-up and of how amyloid is made, two hallmarks of Alzheimer's disease. Lithium also blocks another enzyme, which drains a signalling building block called inositol. Both effects depend on dose. The doses where they have been shown in the human brain are the prescription ones, checked by blood test. The 2025 work adds a different idea. Lithium may be a trace element the brain keeps at a set level. Losing it may be an early step in Alzheimer's disease, and amyloid may trap it, leaving even less available. That work used lithium orotate on purpose, because it sticks to amyloid less than lithium carbonate does. If that idea is right, low-dose lithium would be fixing a shortage rather than acting as a drug. That would be a different kind of claim. It would need a way to measure the shortage in a living person. No such test is in routine use.
What have studies in people found about Low-dose lithium?
Two very different kinds of human data that often get blended. A large set of studies linking tap water lithium to death and suicide rates across places, which cannot tie any result to one person's intake. And a small set of studies that gave people lithium for memory problems. All but one of those used prescription lithium carbonate, at doses far above what supplements give.
- 18 Japanese towns, 1,206,174 people: more tap water lithium went with fewer deaths from any cause. This is a pattern across places.
- A review of 15 place-based studies: more water lithium went with fewer suicides. Its own authors warn that patterns across places may not hold for people.
- 61 people with mild memory problems, 2 years at the same low blood level: the dummy group declined and the lithium group held steady, with better memory and attention at 24 months.
- 45 people with mild memory problems, 12 months of lithium at a blood level of 0.25 to 0.5 mmol/L: a tau protein in spinal fluid fell, and two thinking measures improved.
- Alzheimer's disease, 300 micrograms a day for 15 months: memory and thinking scores held while the untreated group declined. One small study, not repeated.
- No study has tested lithium orotate, the form actually sold, on any result in people.
What this does not tell you: Studies of places compare places. Counties with more lithium in their water differ from others in many ways that have nothing to do with lithium. The review also found the separate studies disagreed with each other a lot. The studies that gave people lithium are small, each run at one center, and used a prescription drug checked by blood test. The doses were roughly a hundred times higher than a typical supplement. The 300 microgram study is the only one at a supplement-like dose, and it stands alone. Nobody has measured whether any of this changes how long a person lives.
What do people who took Low-dose lithium report?
This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.
- The amounts described are very small, commonly in the range of about 1 to 5 mg of elemental lithium daily, usually as the orotate salt, and the justification people give is the concentration found naturally in some drinking water rather than any prescribing standard.
- The reports split sharply and the split is the most striking thing about this discussion. At the same few milligrams, some people describe a subtle reduction in anxiety and others describe pronounced mental fog, short-term memory problems and sleepiness within an hour. Both are reported by regular posters and neither group is fringe.
- Muscle twitching is raised, and the community response to it is typically that the amount is too small to be responsible, which is offered as reassurance rather than demonstrated.
- A published overdose account involving many times the usual amount circulates in these threads and is described as producing nausea and a mild tremor that resolved within hours, and it is used by posters to argue the margin is wide.
- Whether anything at these amounts does anything at all is a live and unresolved argument in the same threads, with long-running discussion of whether single-digit milligram doses can protect the brain at all. Reports of no effect are common and are treated as expected rather than surprising.
Sources: Brain Health and Supplements threads on LongeCity, reached through site-restricted search extracts of the threads because the site itself would not load from this environment, September 2026. Nothing above is attributed to any specific post and no post is reproduced.
The state of the research
The label on this research matters more than usual, so here it is plainly. The tap water studies compare places. They are not tests on people. They cannot show that giving lithium to a person changes that person's risk. The researchers who pooled them say so in their own conclusion. Anyone quoting them as proof that low-dose lithium works is quoting a study design chosen because it was cheap and easy, not because it answers the question.
The second thing to hold onto is the dose mix-up. The phrase low-dose lithium covers two things about a hundred times apart. Lithium carbonate at 150 to 600 mg, adjusted to a blood level of 0.25 to 0.5 mmol/L, is a prescription drug at a reduced dose. It has real evidence behind it in mild memory problems, and it needs real kidney and thyroid checks. Lithium orotate at a few milligrams of lithium is a supplement. It produces no level you can measure in the blood, and no study has tested it on people. Marketing slides between the two as if they were the same thing.
The 2025 Nature work is the most interesting news in this area in years. It is worth being precise about what it is: human brain tissue after death, plus mouse experiments. If its idea holds, low-dose lithium would be topping up a shortage, not acting as a drug. That would fit this site's usual rule about fixing measured shortages. The missing piece is exactly what that rule needs. That is a way to measure the shortage in a living person, and a study showing that fixing it changes a real result.
This archive's position on supplements is simple. You take something because a number on your blood work is out of range. Then you retest, and you stop if the number does not move. That rule is awkward for this group. For most of them there is no shortage to fix, so no blood number tells you whether the bottle is doing anything. Where a compound here does move a number you can read, that number is a stand-in marker, not a shortage. Moving it is not the same as fixing something that was broken.
The evidence, in charts
Fig. 1a · how many people
106people, across 2 studies in people cited here
| Study | People | Share |
|---|---|---|
| British Journal of Psychiatry 2019 | 61 | 58% |
| British Journal of Psychiatry 2011 | 45 | 42% |
One study holds 58% of these people, so the total rests more on one study than its size suggests. Counts are the number of people each study on this page says it signed up. That includes studies that only watched people and gave nobody the compound. 2 more studies in people give no headcount and are not counted here. Studies still signing people up are left out, and only studies cited on this page are counted.
Fig. 1b · evidence mix
4 of 6 sources here are studies in people. The rest are not.
- Study in people · done in people467%
- Animal study · done in animals117%
- Review of studies · sums up other studies117%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 5 different years, 2011 to 2025, counted from the list of sources on this page.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Supplement
- Molecule weight
- Lithium is an element with an atomic weight of about 6.9. Supplements sell it as a salt, usually the orotate, so the elemental dose is a small fraction of the label weight.
- Half-life
- About 24 hoursLong, 1 to 7 days
- Chain length
- None on file
Half-life as stated on file: Roughly 24 hours in plasma for lithium in healthy adults, and longer in older people and in reduced kidney function.
No amino acid sequence is on file for Low-dose lithium, which is expected: a supplement is not built from amino acids.
The studies we cite
- Study in people2011Low-dose lithium uptake promotes longevity in humans and metazoans.
Nobody was given anything in the human half of this paper, and the other half is a worm. Researchers compared how much lithium was in the tap water across 18 neighbouring Japanese municipalities covering 1,206,174 people, and found that places with more of it had fewer deaths. That is a pattern across places, not an effect in a person. Separately, they put roundworms in a similar lithium concentration and the worms lived longer. Towns differ from each other in dozens of ways nobody measured here.
Two separate pieces of work in one short paper. An observational weighted regression across 18 neighbouring Japanese municipalities totalling 1,206,174 individuals found an inverse correlation between tap water lithium concentration and all-cause mortality (beta -0.661, p = 0.003). Separately, exposing Caenorhabditis elegans to a comparably low lithium chloride concentration extended lifespan (p = 0.047). The human half is an ecological correlation between places, not an intervention in people, and the lifespan half is a worm.
- Study in people2011Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial.
Prescription lithium, at a low monitored dose, moved a brain marker and some thinking scores. 45 people with memory problems took lithium or a dummy for a year, nobody knowing which. Doses were adjusted by blood test to a range below the usual psychiatric one. A tau protein in the spinal fluid fell, and scores on an Alzheimer's scale and on attention tasks improved. 91 percent kept taking it. Note the dose. This is prescription lithium carbonate with blood monitoring, not a trace-dose supplement.
45 participants with amnestic mild cognitive impairment randomised to lithium (titrated to 0.25 to 0.5 mmol/L serum, a subtherapeutic range) or placebo for 12 months. Lithium significantly lowered cerebrospinal fluid phosphorylated tau (p = 0.03) and improved the cognitive subscale of the Alzheimer's Disease Assessment Scale and attention tasks. Tolerability was good and adherence 91 percent. Registered as NCT01055392. Note the dose: prescription lithium carbonate monitored by blood level, not a trace-dose supplement.
- Study in people2019Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial.
Over two years the untreated group declined and the lithium group did not. 61 older adults living at home with mild memory problems took low-dose lithium or a dummy for two years, nobody knowing which, then were followed two years more. The dummy group got worse on thinking and on daily function. The lithium group stayed steady. Memory and attention were better at two years. Again this is monitored prescription lithium, not a supplement, and 61 people at one site is small.
61 community-dwelling older adults with mild cognitive impairment randomised to subtherapeutic lithium (0.25 to 0.5 mEq/L) or placebo for 2 years double blind, followed a further 24 months single blind. The placebo group declined cognitively and functionally while the lithium group remained stable; lithium was associated with better memory and attention at 24 months and a significant rise in cerebrospinal fluid amyloid-beta 42 at 36 months. Same registration, NCT01055392.
- Study in people2013Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease.
This is the only trial at a dose anything like the supplements on sale, and it is one small study. People with Alzheimer's disease took 300 micrograms of lithium once a day for 15 months. The treated group's mental state scores held while the untreated group's fell, with the gap opening from three months and widening after that. No other team has repeated it. The report gives little detail about how it was run. One unrepeated small study at a dose nobody else has tested cannot carry a claim.
The only randomised trial located at a dose comparable to supplement products: 300 micrograms of lithium once daily for 15 months in Alzheimer's disease patients. The treated group showed no decrease in mini mental state examination performance while controls declined, with differences appearing from three months and increasing. A single small study, not replicated, and the report gives limited methodological detail.
- Review of studies2020Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies.
A review that pooled 15 studies comparing lithium in local drinking water with local suicide rates. Places with more lithium in the water had fewer suicides overall. The link was clearer in women than in men. The authors warn that patterns across places may not hold for individual people. They suggest adding lithium to some water supplies, chosen by chance, as the real test. Nobody has done that.
15 ecological studies pooled. Inverse association between drinking water lithium and total suicide mortality, pooled beta -0.27 (95 percent CI -0.47 to -0.08, p = 0.006, I squared 83.3 percent); male beta -0.26 was not significant (p = 0.08) and female beta -0.13 was (p = 0.03). The authors state that these studies are subject to the ecological fallacy and bias, and suggest randomised community trials of water supplementation as the way to test the hypothesis. No such trial has been run.
- Animal study2025Lithium deficiency and the onset of Alzheimer's disease.
Mostly in mice. In human brain tissue studied after death, lithium was the only metal clearly lower in people with mild memory problems, and amyloid trapped even more of it in Alzheimer's disease. In mice, cutting dietary lithium by about half raised amyloid and tau, damaged nerve connections and sped up memory decline. Giving lithium orotate prevented this in mice. No person was given lithium.
Endogenous lithium was the only metal significantly reduced in the brains of individuals with mild cognitive impairment, with bioavailability further reduced in Alzheimer's disease by amyloid sequestration. In mice, reducing cortical lithium by about 50 percent through diet increased amyloid-beta deposition and phospho-tau, activated microglia, caused loss of synapses, axons and myelin, and accelerated cognitive decline, partly through GSK3 beta. Lithium orotate replacement prevented pathology and memory loss in mouse models and ageing wild-type mice. Human post-mortem tissue plus mouse experiments; no human intervention. NIH funded.
Common questions
Has Low-dose lithium been tested in people?
Yes. 106 people given it across 3 completed trials cited here, 0 of which found nothing. The tap water studies people quote are not tests on people.
What is the Low-dose lithium dosage?
No human dose established. Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose. 3 completed trials, 106 people given it
Is Low-dose lithium FDA-approved?
Lithium carbonate and lithium citrate are FDA-approved prescription medicines for bipolar disorder. People taking them must have regular blood tests to check their lithium level. Lithium orotate is sold as a dietary supplement. It has no approved use and no required blood tests.
Does lithium in drinking water reduce suicide?
The studies that report this compare places. They set lithium levels in an area's water against that area's death rates, without measuring anyone's own intake or health. Pooled across 15 of them, the link is steady: more lithium, fewer suicides. The review's authors warn that patterns across places may not hold for people. They call for studies that add lithium to some water supplies by chance, and none has been run. It is an idea with support at the level of whole populations, not a proven effect.
Is lithium orotate the same as the lithium in the studies?
Not in the studies that gave people lithium for memory. Those used prescription lithium carbonate at 150 to 600 mg, adjusted to a blood level of 0.25 to 0.5 mmol/L. A lithium orotate supplement usually gives a few milligrams of lithium itself, roughly a hundred times less, and produces no level you can measure in the blood. One small study did use 300 micrograms a day in Alzheimer's disease. It reported steady memory and thinking scores over 15 months. Nobody has repeated it.
What did the 2025 Nature paper actually show?
It showed the brain's own lithium was the only metal clearly lower in people with mild memory problems. In Alzheimer's disease, amyloid traps even more of it. In mice, cutting dietary lithium by about half drove up amyloid and tau, inflamed the brain's immune cells, damaged nerve connections and their coating, and sped up memory decline. Lithium orotate prevented that in mice. It is human tissue plus mouse experiments. No person was given lithium in that study.
Is low-dose lithium safe to take without monitoring?
Prescription lithium needs blood level, kidney and thyroid checks. The gap between a helpful dose and a harmful one is narrow, and long-term use affects both organs. Supplement doses of orotate are far below that range and produce no measurable blood level. That is why it is sold without checks. It is also why there is no way to tell whether you are getting a dose that does anything. This site does not give dosing advice. The point is that no checks and no measurable effect are the same fact.
Does it extend lifespan?
No human study has measured lifespan. The lifespan claim traces back to a 2011 paper. It paired a pattern across 18 Japanese towns with a worm experiment, where low-dose lithium chloride made the worms live longer. A pattern between places, and a result in a worm.